Jing Xu
机构：Fujian Medical University, Guiyang Medical University, Duke University, Xuzhou Medical College, Chinese University of Hong Kong, Dalian Medical University, Ragon Institute of MGH, MIT and Harvard, Zhejiang Ocean University, Wuhan University, Nanjing Children's Hospital, Second Affiliated Hospital of Chongqing Medical University, Huaian First People’s Hospital, Nanjing Maternity and Child Health Care Hospital, Capital Institute of Pediatrics, Affiliated Hospital of Guizhou Medical University, Second People’s Hospital of Huai’an, Duke Medical Center, Yancheng Third People's Hospital, Second Affiliated Hospital of Fujian Medical University, Shanghai University of Medicine and Health Sciences, Education Department of Jiangxi Province, Renmin Hospital of Wuhan University, Wuyi University, Jiangsu Province Hospital, Duke University Hospital, First Hospital of Lanzhou University, First Hospital of Xi'an, Shaanxi University of Chinese Medicine, Lanzhou University, Nanjing Medical University, Chongqing Medical University · ORCID：0000-0002-8050-6831
发表论文 260 篇 · 总被引 7850 次 · h-index 45
代表论文
- GPR37L1 identifies spinal cord astrocytes and protects neuropathic pain after nerve injury (2025 · Neuron · 被引 41)
- Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain (2025 · Cell · 被引 35)
- Sanguinarine chloride induces ferroptosis by regulating ROS/BACH1/HMOX1 signaling pathway in prostate cancer (2024 · Chinese Medicine · 被引 34)
- GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota (2023 · European Journal of Pharmacology · 被引 31)
- Hevin/Sparcl1 drives pathological pain through spinal cord astrocyte and NMDA receptor signaling (2022 · JCI Insight · 被引 26)
- The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy (2023 · Frontiers in Oncology · 被引 14)